TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive In Brief: ACS Awards Professorship To Bernstein; HCFA Clears Dana-Farber For Medicare August 11, 1995
TCL Archive More Than 450 Mammography Facilities Are Accredited By American College of Radiology April 7, 1989